MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  

Renowned Dermatologist Dr. Michael H. Gold Joins AIVITA Scientific Advisory Board

IRVINE, Calif. – September 21, 2017 – AIVITA Biomedical, a clinical research company and commercial skincare product developer, announced today…

AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth

IRVINE, Calif. September 19, 2017 – AIVITA Biomedical today announced the discovery of a new method for capturing and using…

AIVITA Comments on Positive Findings from Asterias’ SCiStar Trial for Spinal Cord Injury

IRVINE, C.A., June 13, 2017 – AIVITA Biomedical offered its congratulations today following the announcement of positive 9-month efficacy…

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Speak at Stem Cell Cures Consortium Conference

IRVINE, Calif. – June 7, 2017 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be…

AIVITA Appoints Operations and Customer Care Executive Ed Inal as Chief Operating Officer

IRVINE, Calif. – May 3, 2017– AIVITA Biomedical today announced the appointment of operations executive Ed Inal as Chief…

AIVITA Biomedical to Feature Skin Care Technology at Upcoming Music City SCALE Symposium

IRVINE, Calif. – May 2, 2017 – AIVITA Biomedical today announced that it will be appearing at the upcoming Music…

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Present as Distinguished Speaker at Upcoming Stem Cell Summit 2017

IRVINE, Calif. – April 3, 2017 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be…

AIVITA Biomedical to Present Skin Care Technology and Products at 15th Annual South Beach Symposium

IRVINE, Calif. – February 7, 2017 – AIVITA Biomedical today announced it will present details of its patented skin…

AIVITA Biomedical Launches PROVOQUE Eye Complex

IRVINE, Calif. – February 2, 2017 – AIVITA Biomedical today announced the launch of PROVOQUETM Eye Complex, a patented…

AIVITA Biomedical Awarded NIH R01 Grant for Development of 3D-Transplantable ‘Retinas’

IRVINE, Calif. – September 29, 2016 – AIVITA Biomedical, a stem cell company with clinical and commercial programs, today…

  • Previous
  • 10
  • 11
  • 12
  • 13
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Publishes a Universal Dendritic Cell Cancer Vaccine Platform
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Global Health and Vaccine Readiness Leader Larry Brilliant
  • AIVITA Biomedical Nominated for 2026 Prix Galien USA Award
  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.